生命科学资讯

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

FDA clears Encora Therapeutics’ wearable wrist device for essential tremor

What were the biggest clinical trial flops of 2025?

After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio

Gilead gets cancer drug from China-based Genhouse for $80M upfront

Pentagon adds, then withdraws, WuXi AppTec to Chinese military list

Lilly appeals retatrutide classification ruling in case that could impact compounders

In the clinic for Feb. 13, 2026

Other news to note for Feb. 13, 2026

Regulatory actions for Feb. 13, 2026

Money raised by biopharma

Biopharma money raised: Jan. 1-Feb. 12, 2026

Why Is 10x Genomics (TXG) Stock Soaring Today - FinancialContent

Epigenetic editing startup Moonwalk shifts focus to siRNA for obesity

Chutes & Ladders—Sanofi's stunning CEO switch

Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site

Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg

Lyell starts first-of-its-kind CAR-T trial; New coalition aims to boost European biotechs

Lundbeck migraine prevention drug succeeds in Phase 2, advancing new therapy class

Moderna's flu shot dilemma muddies 2028 break-even guidance